Jardiance Empagliflozin 25mg Blood Sugar Control Diabetes Tablets 30s

• Jardiance 25mg Tablets – empagliflozin 25mg film-coated tablets (30 tablets) • First-in-class SGLT2 inhibitor for type 2 diabetes mellitus • Once-daily oral tablet that lowers blood glucose by removing excess sugar through urine • Triple cardiovascular & renal protection: reduces risk of CV death by 38%, heart failure hospitalization by 35%, and kidney disease progression • Proven weight loss (~2–3kg) & modest blood pressure reduction • Suitable for adults with T2DM – monotherapy or add-on to metformin, insulin, etc. • Prescription medicine – gold-standard in modern diabetes care

Jardiance 25mg (empagliflozin) blocks SGLT2 in the kidneys, causing ~80–100g of glucose to be excreted in urine daily. Landmark trials (EMPA-REG OUTCOME, EMPEROR-Reduced/Preserved, EMPA-KIDNEY) demonstrated unprecedented benefits in: Reducing cardiovascular death in T2DM with CVD Preventing & treating heart failure (with or without diabetes) Slowing chronic kidney disease progression Maximum glucose-lowering effect reached in 1–2 weeks; full CV/renal benefits accrue over months to years. Benefits • Reduces A1c by 0.7–1.0% • Low risk of hypoglycemia (unless combined with insulin/sulfonylurea) • Promotes 2–4kg weight loss & 3–5mmHg systolic BP drop • Only once-daily dosing – morning, with or without food • Proven to extend life & protect heart/kidneys in large trials • Film-coated tablet – easy to swallow • Cost-effective generic versions Now available in many markets How to Use • Take 1 tablet (25mg) once daily in the morning • Can be taken with or without food • Swallow whole with water • Starting dose usually 10mg; increase to 25mg if tolerated & more control needed • Continue indefinitely unless advised otherwise by doctor • Regular kidney function & weight monitoring recommended • Store below 30°C in original packaging